Association between Khorana score and prognosis in cancer patients with stage IV treated with immune checkpoint inhibitors ∼ factor analysis in Khorana score related to overall survival
Our results suggested that Khorana score at the start of ICIs treatment was related to prognosis of patients with stage IV cancer. In particular, Hb level < 10 g/dL before commencement of treatment was shown to be an independent risk factor affecting prognosis.
Authors
- Takayuki Ide (ORCID: https://orcid.org/0009-0002-3094-1445)
- Tomonobu Koizumi (ORCID: https://orcid.org/0000-0002-5182-0960)
- Taisuke Araki (ORCID: https://orcid.org/0000-0002-8033-868X)
Institutions
- Shinshu University (JP)
- Shinshu University Hospital (JP)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-09-29
- DOI
- https://doi.org/10.3389/fimmu.2025.1633398
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00